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ABSTRACT 
Colchicine,  vinblastine,  and  vincristine  inhibit  the  mitogenic  stimulation  of 
lymphocytes by concanavalin A  as measured by the incorporation of [SH]thymi- 
dine and the appearance of blast cells. The inhibitory effect of colchicine could not 
be accounted for by diminution in cell viability or by metaphase arrest of mitosis in 
the stimulated cells. Moreover, the inhibition of [SH]thymidine incorporation was 
not  due  to  blockage  of  thymidine  transport  or  inhibition  of  DNA  synthesis 
inasmuch as addition of colchicine had no effect on cells in the S phase of the cell 
cycle.  The  time  of  inhibition  was  correlated  with  the  kinetics  of  cellular 
commitment  to  lectin  activation  and  the  kinetic  data  indicated  that  colchicine 
blocks  stimulation  early  in  the  sequence  of  events  following  addition  of  the 
mitogen.  These  findings  support  the  hypothesis  that  cytoplasmic microtubular 
function plays a role in the commitment of resting cells to undergo mitotic division. 
Although the  detailed  mechanism  of lymphocyte 
stimulation  by mitogens  such  as concanavalin  A 
(Con A)  1  is not understood,  it is generally assumed 
that specific interactions  between certain  cell sur- 
face receptors  and the mitogen are responsible for 
the subsequent activation  of the appropriate meta- 
bolic machinery  in the cytoplasm  and nucleus (4, 
12). On the basis of studies on the modulation of 
lymphocyte  surface  receptor  mobility  by  tetra- 
merit native Con A (40), dimeric  succinyl-Con A 
(14), and colchicine and related  drugs  (8, 41, 42), 
we have  suggested  the hypothesis  that the  mem- 
brane receptor-cytoplasmic  interactions  are medi- 
ated by an assembly of colchicine-binding proteins, 
most likely the microtubules.  It was also suggested 
that  direct  or  indirect  interactions  between  cell 
surface  receptors  and  microtubules  may be  con- 
1Abbreviations used in this paper: Con A, concanavalin 
A; aMM, a-methyl-D-mannoside;  PBS, phosphate-buff- 
ered saline: 8.00 g NaCI, 0.20 g KCI, 1.15 g Na~HPO,, 
0.20 g KH~PO, per liter, pH 7.4; PHA, phytohemag- 
glutinin. 
nected  with  the  initial  events  of  lectin-induced 
mitogenesis (8). In accord with this hypothesis, we 
found that colchicine inhibits the incorporation  of 
[SH]thymidine in mouse splenic lymphocytes stim- 
ulated by Con A (8). Subsequent  studies on human 
peripheral  blood  lymphocytes activated  by phy- 
tohemagglutinin  (PHA) have  revealed similar  ef- 
fects  of colchicine  and  pharmacologically  related 
drugs (26). 
In the present investigation, a number of experi- 
ments have been carried out to analyze the kinetics 
and biochemical  sites of the inhibitory  activity of 
colchicine. The effects of the drug on cell viability, 
incorporation of thymidine into DNA, blast trans- 
formation, and  mitosis  have  been studied  in  cul- 
tures of lymphocytes  from man and in some cases 
from the  mouse.  Colchicine  was found to inhibit 
both the incorporation of [aH]thymidine and blast 
transformation  that  occur  after  stimulation  by 
Con A. Analysis of the kinetic data suggests that 
colchicine  inhibits  mitogenic  stimulation  early  in 
the  sequence  of events  following addition  of the 
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terms of a  recent  analysis  (13)  of the kinetics of 
cellular  commitment  during  the  stimulation  of 
lymphocytes by lectins. This interpretation is con- 
sistent  with  the  hypothesis  that  colchicine  acts 
before the commitment of the cell to enter into the 
S  phase of the division cycle. 
MATERIALS  AND  METHODS 
Reagents 
Con A and succinyi-Con A were prepared as described 
previously  (7,  14). Lumicoichicine was  prepared  from 
colchicine  (Sigma  Chemical  Co.,  St.  Louis,  Mo.)  by 
ultraviolet irradiation following the method  of Wilson 
and Friedkin (39). The following materials were obtained 
commercially  and  used  without  further  purification: 
vinblastine sulfate  and  vincristine sulfate (Eli  Lilly  & 
Co., Indianapolis, Ind.), hydroxyurea (Calbiochem, San 
Diego, Calif.), sodium metaperiodate (Matheson, Cole- 
man  &  Bell,  Norwood,  Ohio),  Salmonella  typhosa 
lipopolysaccharide (Difco Laboratories, Detroit, Mich.), 
a-methyl-o-mannoside (aMM)  (General Biochemicals, 
Chagrin  Falls,  Ohio),  [SH]thymidine  (Schwarz-Mann 
Div., Becton, Dickinson, & Co., Orangeburg, N. Y.), and 
[aH]colchicine (New  England Nuclear, Boston, Mass.). 
Cell  culture  media,  antibiotics,  glutamine,  pyruvate, 
nonessential amino acids, horse serum, and fetal bovine 
serum  were  obtained from  Microbiological Associates 
(Bethesda, Md.). 
Cell Culture 
Human  peripheral blood  lymphocytes  were  isolated 
from  the  blood  of normal donors  by density gradient 
centrifugation (6). Cultures were set up at a cell concen- 
tration  of  I  ￿  106  celis/ml  in  RPMI  1640  medium 
containing  20%  heat-inactivated  fetal  bovine  serum. 
Experiments  were  performed  in  12  ￿  75-ram  tubes 
(Falcon  No.  2054,  Falcon  Plastics,  Div.  of  BioQuest, 
Oxnard, Calif.) in a final volume of 1.0 ml. Con A, when 
present,  was  at  a  final  concentration  of  20  ,g/ml, 
previously  determined  to  be  an  optimally  stimulating 
dose.  Cultures  were  maintained  at  37~  in  a  humid 
atmosphere of 10% COs, 7% 02, 83% Ns. 
Rabbit peripheral lymphocytes were prepared as de- 
scribed by Sell and Gell (33) and maintained in modified 
Eagle's minimum essential medium containing 10% fetal 
bovine serum. Cultures were set up in 12 ￿  75-ram tubes 
containing a  final volume of 1.0 ml per tube. The cell 
concentration was 3  ￿  10  a cells/ml. 
Murine lymphocytes were from spleens of NCS mice 
(The  Rockefeller  University, New  York)  and  athymic 
nu/nu mice bred on a  BALB/c background. A detailed 
description of the procedure for culturing mouse splenic 
lymphocytes has been given elsewhere (13). The methods 
used for periodate and iipopolysaccharide stimulation of 
mouse splenic lymphocytes have also been described (25). 
Assay of DNA Synthesis 
Cells  were  pulsed  with  6  ~Ci/culture  of  [aH]thymi- 
dine (1.9 Ci/mmol, Schwarz-Mann) between 48 and 50 h 
after the addition of the mitogen. After the pulse, cells 
were deposited on Whatman GF/A filters, washed with 
phosphate-buffered saline (PBS), 5% trichloroacetic acid, 
and  methanol,  dried,  and  counted  in  a  scintillation 
counter  in  5  ml  of  0.4%  Omnifluor  (New  England 
Nuclear) in toluene (13). 
To compare the kinetics of thymidine incorporation in 
Con A-stimulated cultures in the presence and absence of 
colchicine, parallel  cultures were  given a  terminal 6-h 
pulse of [aH]thymidine (6 ttCi/culture,  1.9 Ci/mmol) at 
various times after Con  A  addition and  harvested for 
scintillation counting. Similarly, the kinetics of thymi- 
dine incorporation were also determined in the presence 
and absence of colchicine on cells stimulated by Con A 
and collected at the G1/S boundary using hydroxyurea 
(see below). In this case, a  l-h pulse of [SH]thymidine (6 
~Ci/cuiture,  1.9 Ci/mmol) was used. 
Assay of Blast Transformation 
Two procedures were used to determine the number of 
human lymphocytes undergoing blast transformation. In 
the  first method, cells were smeared on gelatin-coated 
slides,  fixed in methanol, stained in Giemsa, dipped in 
xylene and mounted in Permount (Fisher Scientific Co., 
Pittsburgh,  Pa.)  for  observation.  Slides  were  scanned 
from the leading edge of the cell smear to the end of the 
slide. Blast cells were identified on the basis of their size 
(> 9 ttm), low nuclear-to-cytoplasmic ratio, and in most 
cases a clearly visible nucleolus. 
In the second method, aliquots of cultures were dilu- 
ted with an equal volume of trypan blue and then loaded 
in  a  corpuscle  counting  chamber  (Hausser  Scientific, 
Blue  Bell,  Pa.).  The  numbers of leucocytes  and  blast 
cells in an area of 5 mm  2 were counted using the size of 
the cell and the nucleus-to-cytoplasm ratio to discrimi- 
nate blast cells from nonresponding leucocytes.  Photo- 
graphs  of  representative small  lymphocytes  and  blast 
cells are shown in Fig.  I  a-c. When the percentage of 
blast cells was determined from the same culture using 
the two methods described above, it was found that the 
hemocytometer  method  overestimated  the  number  of 
blasts when compared with counts on fixed  and stained 
cells. This may be due to difficulty in determining in the 
hemocytometer  the  nuclear-to-cytoplasmic  ratio,  a 
criterion  important  for  distinguishing blast cells  from 
large  monocytes  in  the  stained  smears.  It  should  be 
noted, however, that using either counting method, the 
percentage of blast cells in cultures containing coichicine 
was clearly different from those without the drug.  Fur- 
thermore, an increase in the percentage of btasts upon 
stimulation, as detected by the hemocytometer method, 
was always paralleled by a proportionate increase when 
assayed by the fixed cell method. 
In addition, the method of assaying for blast transfor- 
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vations which require some explanation. First, cultures 
with Con A contained small clumps of agglutinated cells. 
The  individual  cells  in  these  clumps  could  not  be 
distinguished  so  that  the  absolute  number  of  cells 
counted in cultures containing Con A was always 30-40% 
lower when compared to cultures without Con A. Efforts 
to  minimize  the  agglutination  effect  using  a  weaker 
agglutinin such as succinyI-Con A (14) still resulted in a 
difference  between  lectin  cultures  and  cell  controls. 
Inasmuch as this difference was apparent whether or not 
colchicine was present, we believe that it does not affect 
the comparisons of the kinetics of appearance of blast 
cells in Con A-stimulated cultures with and without the 
drug. 
The  second  observation  concerns  the  presence,  in 
cultures  without  Con  A,  of  cells  large  enough  to  be 
counted as blasts but which did not resemble the blast 
ceils present in cultures containing Con A. The appear- 
ance of these large cells (Fig.  ! d-f) suggested that they 
were monocytes containing many phagocytized particles. 
Preliminary  experiments  have  also  shown  that  these 
phagocytic cells take up colloidal carbon. Because count- 
ing these unidentified leucocytes as blast cells would have 
overestimated the  percentage  of blast cells  in the cell 
control cultures, we arbitrarily placed these cells in the 
category  of  unstimulated  cells.  It  should  be  noted, 
however, that these cells were noticeable only in control 
cultures  and  they  never  exceeded  10%  of  the  total 
population. 
Finally, the morphology of cells in colchicine-treated 
cultures  needs  special  comment.  Large  blastlike  cells, 
when they do appear, are much more irregular in shape 
than blast cells in cultures containing Con A alone (Fig. 1 
g-i).  The  size  of  each  of  these  cells  was  judged  by 
estimating the diameter the cell would  have if it were 
rounded  out  to  a  circular  shape.  In  contrast,  some 
lymphocytes  not  responsive to  Con  A  stimulation ap- 
peared to shrink in size when exposed to colchicine for a 
long time while others assumed  an irregular shape or 
showed dark granules (Fig. I j-/). These effects were only 
noticeable after 40 h  of exposure. Similar alterations in 
cell shape have been observed in rat peritoneal mast cells 
and  mononuclear cells treated  with  colchicine in  vivo 
(28). 
Sychronization  of Stimulated L ymphocytes 
at the G t/S Boundary 
Lohrmann et al. (22) have observed that dog lympho- 
cytes stimulated by PHA can be collected at the GI/S 
boundary  using 4  mM  hydroxyurea.  We found that 2 
mM hydroxyurea completely blocked DNA synthesis in 
Con  A-stimulated human  lymphocytes without any ef- 
fects  on  cell  viability for  periods  as  long  as  40  h  of 
exposure to the drug. Cultures stimulated with Con A 
were therefore made 2 mM in hydroxyurea 30 h after the 
addition of the mitogen. At 54 h, colchicine was added to 
half of the cultures at a final concentration of 10  -e M. At 
60 h, all cultures were washed to remove hydroxyurea. 
The washing solution was complete RPMI  1640 medium 
containing 20 pg/ml Con A  which had been incubated 
along  with  the  cultures  from  the  beginning  of  the 
experiment and one half of which was also made 10  -~ M 
in colchicine at  54 h.  The  cultures,  with  and  without 
colchicine, were resuspended in  1 ml of their respective 
medium. Cell viability and [SH]thymidine incorporation 
were determined at various times after the removal of 
hydroxyurea. 
Reversibility  of the Colchicine Effects 
The  rates  of uptake  and effiux of [SH]colchicine in 
human lymphocytes were determined as follows: cultures 
containing  20  ,g/ml  Con  A  were  made  10  -6  M  in 
[SH]colchicine (3 Ci/mmol) and a set of 10 cultures was 
immediately washed  in complete RPMI  1640  medium 
containing 20 ~g/ml Con A. Two of the washed cultures 
were deposited on GF/A filters, rinsed with 10 ml of cold 
PBS,  and  taken  for  scintillation  counting.  Duplicate 
cultures were also taken for counting at 6,  12, and 24 h 
after the washing with complete medium and also at 48 h 
after the addition of [JH]colchicine. The washing proce- 
dure was similarly performed on other sets of cultures at 
various times after the addition of [aH]colchicine and 
FIGURE  1  Photographs of representative cells observed in cultures of human lymphocytes stimulated by 
Con  A  in the presence and  absence of colchicine: (a),  unstimulated small iymphocytes in cell control 
cultures; (b and c), blast cells in cultures stimulated by Con A. Both the nucleus and the nucleolus can be 
seen; (d-J), large blastlike cells in cultures without Con A with phagocytic particles and dense collections of 
granules. The nuclei in these cells were not readily discernible; (g-0, blast cells in cultures stimulated by 
Con A in the presence of colchicine. The cells assume a flatter shape'with irregular boundaries. The nucleus 
can  be distinguished from  the cytoplasm; (J-0,  small lymphocytes  in cultures containing Con  A  and 
colchicine. These cells appear to be nonresponsive to lectin stimulation. They assume irregular shapes and 
acquire dark granules after prolonged exposure to colchicine. The photographs were taken on a  Zeiss 
Universal microscope using phase contrast optics and Kodak  Panatomic-X film (Eastman Kodak Co., 
Rochester, N. Y.). The magnification factor for all photographs was ￿  1,250. The bar represents 10/~m. 
Con A and colchicine, when present, were used at concentrations of 20 ~g/ml and 10  -e M, respectively. 
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respective times. 
To test for the reversibility of the effects of colchicine 
on  human  lymphocytes, cells were incubated without 
Con A in the presence and absence of colchicine for 6 h. 
At  this  time,  all  cultures  were washed twice with 
complete medium and resuspended  in the original volume 
of complete medium without colchicine. 54 h after the 
beginning of the experiment, cell viabilities were deter- 
mined for cultures previously exposed and unexposed to 
colchicine.  The cells were then washed once, made up to 1 
x  106 viable cells/ml in fresh medium, and cultured with 
and without 20 #g/ml Con A for another 48 h, at which 
time they were pulsed with [SH]thymidine  (6 #Ci/culture, 
1.9 Ci/mmol, 2 h) for determination of DNA synthesis. 
RESULTS 
We have previously observed that colchicine inhib- 
its the  incorporation of [SH]thymidine in mouse 
splenic lymphocytes stimulated by Con A  (8).  In 
the  present  experiments,  we  found that  l0  -6  M 
colchicine inhibits the response of human, murine, 
and  rabbit  lymphocytes  to  Con  A  by  about 
70-90%,  as  measured  by  the  incorporation  of 
[SH]thymidine between 48 and 50 h after the start 
of the culture. A  similar inhibitory effect  of col- 
chicinr was observed in the stimulation of mouse 
splenic lymphocytes by sodium metaperiodate and 
in  the  stimulation of  spleen  cells  from  athymic 
nude mice by lipopolysaccharide. In addition, we 
found  that  other  antimitotic drugs  such  as  vin- 
blastine and vincristine also inhibited the response 
of  both  human  and  murine  lymphocytes  to 
Con A. 
Experiments  were  performed  to  answer  the 
following questions: (a) Can the inhibitory  effect of 
colchicine be accounted for by diminution in cell 
viability or  by arrest  of mitosis at metaphase in 
stimulated cells? (b) Does colchicine inhibit DNA 
synthesis or thymidine transport in prestimulated 
blast cells? (c) Does the inhibition by colchicine of 
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FIOURE 2  The  effect  of  the  concentration  of colchicine on  [SH]thymidine incorporation in human 
lymphocytes stimulated by Con A. Colchicine was present from the beginning of the experiment. The 
cultures  were pulsed with 6 #Ci of [SH]thymidine between 48 and 50 h. 0,  incorporation by cultures 
containing Con A (20 #g/ml); O, incorporation by cultures in the absence of Con A. 
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before the onset of blast transformation and DNA 
synthesis? (d) Is the effect of colchicine reversible 
upon removal of the drug? 
Because human lymphocytes stimulated by Con 
A  retained a high level of viability under a variety 
of culture conditions, we chose to study this system 
extensively to determine the sites of the inhibitory 
activity  of  colchicine.  The  degree  of  inhibition 
produced by various concentrations of colchicine 
in  the  stimulation  of  human  peripheral  blood 
lymphocytes  by  Con  A  is  shown  in  Fig.  2.  At 
concentrations  of  10 -7  M  or  above,  colchicine 
reduced  the  response  to  Con  A  by  about  70%; 
below  10 -7  M,  the  drug  had  little or  no  effect. 
Because  of the  sharp  dose  dependence  between 
10 -7 and 10 -8 M  (Fig. 2), subsequent experiments 
were performed using  10  -6 M  colchicine to avoid 
drastic  changes  in  the  extent  of inhibition  that 
might result from slight variations in the concen- 
tration of the drug. 
Inhibition of [SH]Thymidine Incorporation 
To test whether the effect of colchicine is due to 
a  shift  in  the  onset  of  DNA  Synthesis  or  to  a 
decrease in the final level of synthesis, the kinetics 
of thymidine incorporation were compared in Con 
A-stimulated cultures in the presence and absence 
of colchicine  (Fig.  3).  It  was  found  that  DNA 
synthesis  in  cultures  without  colchicine  began 
about 30 h after initial Con A binding. In contrast, 
cultures containing colchicine showed only a  low 
level of DNA synthesis as late as 51 h. These data 
suggest that colehicine inhibits mitogenic stimula- 
tion of lymphocytes by blocking an event occurring 
as early as the first wave of DNA synthesis in the 
sequence of events following lectin addition. 
After  51  h,  the  level  of  DNA  synthesis  in 
cultures containing colchicine began to rise, attain- 
ing, at 70 b, about 30% of the level seen in cultures 
without the drug. This small rise in [SH]thymidine 
incorporation  at  late  times  may  indicate  that 
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FXGURE 3  The effect of colchicine on the kinetics of [aH]thymidine incorporation in human lymphocytes 
stimulated  by Con A. Colchicine  was present from the beginning of the experiment.  At various times, 
parallel cultures  were pulsed with 6 #Ci  of [SH]thymidine  for 6  h.  Data points are the  averages of 
measurements on duplicate cultures and are plotted at times corresponding to 3 h after the start of each 
pulse. @, cultures containing Con A (20 #g/ml); l,  cultures containing Con A (20 ~g/ml) +  colchicine 
(10-' M), O, cr  control (CC). 
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DNA  synthesis  in  Con  A-stimulated  cultures. 
Alternatively, it may represent a small population 
of cells escaping the early colchicine block. After 
70  h,  the  level  of  DNA  synthesis  in  cultures 
containing colchicine remained constant. The final 
level  in cultures containing colchicine was about 
30%  of that observed in the absence of the drug. 
Further analysis of the difference in the final levels 
of  synthesis  between  cultures  with  and  without 
colchicine was not attempted for these late times 
because  of  the  complexities  introduced  by  the 
appearance of second generation cells in cultures 
without the drug. 
Inhibition of Blast Transformation 
The  effect  of colchicine on the  stimulation of 
lymphocytes by Con A was manifested not only by 
a  depressed  level  of [SH]thymidine incorporation 
but  also  by  a  decrease  in  the  percentage  of 
lymphocytes transformed into blast cells.  Fig.  4 
and Table 1 show  the  results of a  representative 
experiment to  determine the  kinetics of appear- 
ance of blast cells in the presence and absence of 
colchicine.  By  counting  blast  cells  in  Giemsa- 
stained cell smears taken from cultures at various 
times, it was  found that the percentage of blasts 
began  to  rise  between  24  and  30  h  after  the 
addition of Con A,  while  the corresponding per- 
centages in cell control cultures or cultures con- 
taining colchicine showed  no appreciable increase 
up  to  about  50  h  (Fig.  4).  After  50  h,  the 
percentage  of  blast  cells  in  cultures  containing 
colchicine  showed  a  small  rise,  paralleling  the 
small increase in the level of DNA synthesis seen 
in Fig. 3. 
Using the  hemocytometer counting method to 
determine  the  absolute  number  of  blasts  and 
unstimulated lympbocytes, we performed a  more 
detailed analysis on the same cultures from which 
the  data  in  Fig.  4  were  obtained.  The  results, 
tabulated  in  Table  I,  show  that  although  some 
blast  cells  were  observed  in  cultures  containing 
colchicine,  the  absolute  number  as  well  as  the 
percentage  of  these  blasts  was  lower  than  in 
parallel cultures without the drug.  A  Student's t 
test on these data showed that the differences in the 
number of blast cells  after 30 h  between cultures 
with and without colchicine were significant to the 
1%  level.  Bearing in  mind the  differences noted 
previously on the hemocytometer and cell smear 
counting methods  (see  Materials and  Methods), 
we conclude from the combined results of the two 
methods that colchicine also inhibits blast trans- 
formation. 
Using the  hemocytometer counting procedure, 
we also observed that,  up to 46 h  of exposure to 
colchicine,  the  number  of  viable  leucocytes  in 
cultures with  the  drug  was comparable with  the 
corresponding number in  cultures containing no 
colchicine (Table I). After 46 h, the total number 
of  cells  in  cultures  with  colchicine  was  always 
lower  than  the  number in  cultures  without  the 
drug. It should be noted, however, that the differ- 
ence in the total number of cells in the two cultures 
became significant only at  late times when com- 
plexities such as the appearance of daughter cells 
must be considered in the analysis of cell numbers. 
Inasmuch as  the  differences in the  number and 
percentage  of  blast  cells  in  cultures  with  and 
without colchicine are clearly discernible at times 
much earlier than 40 h after the addition of Con A, 
we  conclude that  the  early effects  of colchicine 
cannot be ascribed to any appreciable decrease in 
cell viability in the presence of the drug. 
Effect of Colchicine on Blast Cells 
jrom Stimulated Cultures 
In order to test whether the depressed  level  of 
blast  cells  in  colchicine-containing cultures  was 
due to selective  killing of these cells,  lymphocytes 
stimulated by Con  A  were  synchronized using 2 
mM hydroxyurea. Colchicine was added to half of 
the  cultures 6  h  before the  removal of hydroxy- 
urea. After the release of the hydroxyurea block, 
the numbers of viable small lymphocytes and blast 
cells as well as the level ofthymidine incorporation 
were determined. For at least 30 h of exposure to 
colchicine, there was no appreciable difference in 
the numbers of blast cells and small lymphocytes 
(Fig.  5 a  and b).  Colchicine, therefore, does not 
exert  its  toxic  effects  selectively on  blast  cells. 
These  results  suggest  that  the  difference  in  the 
number of blast cells in cultures with and without 
colchicine (Fig. 4) represents a true inhibition by 
the  drug  of  the  transformation  process  from  a 
small resting lymphocyte into a blast cell. 
In addition, the data on [3H]thymidine incorpo- 
ration  by  blast  cells  formed  in  the  absence  of 
colchicine  but  arrested  at  the  GI/S  boundary 
showed that colchicine had no effect on the level of 
incorporation (Fig.  5 c).  Under these conditions, 
therefore,  colchicine  appears  to  affect  neither 
[SH]thymidine transport across the membrane nor 
the process of DNA synthesis itself.  This suggests 
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FIGURE  4  The effect  of colchicine on  the kinetics of appearance of blast ceils in  human lymphocyte 
cultures  stimulated by  Con  A.  Coichicine was present  from  the  beginning of the  experiment.  At  the 
indicated times, aliquots of cultures were removed, stained with Giemsa, and the total number of small 
lymphocytes and  blast  cells was counted  (see  Materials and  Methods).  The  data  is expressed as the 
percentage of blast cells present at various times after the addition of Con A. O, cultures containing Con A 
(20 ~g/ml); II, cultures containing Con A  (20 t~g/ml) +  colchieine (10  -~ M); O, cell control (CC). 
TABLE  I 
The Effect of Colchicine on the Number of Cells Transformed by Con A* 
Cell control 
Con A 
Con A +  col- 
chicine 
Conditions 
Smalllympho- 
cytes 
Blasts 
Smalllympho- 
cytes 
Blasts 
Small lympho- 
cytes 
Blasts 
0  12 
10.3  11.8 4- 2.0 
0.53  0.53 4- 0.26 
--  5.52 ~- 0.84 
--  0.164-0.08 
--  7.44 •  0,52 
--  0.16 4- 0~08 
Hours in Culture 
27 
10.1 •  1.6 
0.68 :~ 0.26 
7.00 4- 0.64 
1.04 4- 0.72 
7.56 4- 1.78 
0.20 4- 0.26 
34 
10.5 ~  0.8 
0.60 -~ 0.34 
4.48 :~ 0.68 
1.96 ~ 0.37 
6.40 ~ 0.72 
0.24 •  0.06 
46  55  67 
11.3 +0.7  12.0•  1.8  12.0•  1.2 
0.28•  0.35-~0.20  0.20+0.11 
5.20 + 0.80  4.20 •  0.76  4.08 •  0.56 
2.60~0.14  3.16•  3.72~-0.99 
4.80 +  1.80  4.48 -4- 1.20  3.80  •  0.84 
0.40+0.14  0.76-,-0.25  0.76• 
* Number of cells are averages of results from triplicate  cultures expressed as: (ceils per ml) x  10  +' •  I SEM. 
that the depressed level of [gH]thymidine incorpo- 
ration seen in cultures containing colchicine (Figs. 
2 and 3) represents an inhibitory effect of the drug 
acting on the lymphocytes prior to their transfor- 
mation into blast cells. 
Comparison of the Inhibitory  Effects 
of aMM and Colchicine 
In  previous  studies,  we  observed  (13)  that  if 
aMM,  a  competitive  inhibitor  of  Con  A,  is 
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FIGURE 5  The effect of colchicine on the viability and [=H]thymidine incorporation of human lymphocyte 
cultures stimulated by Con A and arrested at the GJS boundary. Blast cells were collected at the Gt/S 
boundary using 2 raM hydroxyurca, and coichicine was added to half of the cultures 6 h before the re- 
moval of hydroxyurea (sr162  Materials and Methods).  The data arc expressed  as the absolute numbers of 
blast cells (a) and small lymphocytes  present (b) and the level of [=H]thymidine  incorporation (c) at 
various times after the removal of hydroxyurea. The cell numbers in (a) and (b) were determined by count- 
ing in a  hemocytometer. Each point represents the mean of three independent determinations and the 
vertical bars represent •  I SEM. Data points for [=H]thymidine incorporation in (c) (6/~Ci/culture, l-h 
pulse) are the averages of measurements on duplicate cultures. O, cultures containing Con A (20 #g/ml); 
I1, cultures containing Con A (20/~g/ml) +  colchicine (10-' M). 
introduced  at various times after the addition of 
the mitogen to cultures of mouse splenic lympho- 
cytes, the incorporation of [*H]thymidine as mea- 
sured  at  48  h  is  at  least  partially inhibited. No 
inhibition  was  observed  if  the  saccharide  was 
added  20  h  after  the  addition  of  Con  A;  and 
thereafter, aMM  had no effect on the level of the 
response.  In the case  of mouse lymphocytes, the 
rising level  of  [SH]thymidine incorporation with 
later times of aMM  addition was proportional to 
the  number of cells committed to  lectin stimula- 
tion. When aMM  was introduced at various times 
after the addition of Con A  to cultures of human 
lymphocytes,  the  incorporation of [SH]thymidine 
at 48 h  was inhibited in a  fashion similar to that 
previously observed  in  the  stimulation of mouse 
136  THE JOURNAL OF CELL BIOLOGY-VOLUME 66,  1975 lymphocytes  (Fig.  6  a).  The  minor  difference 
between the two systems concerns the time after 
which aMM addition has no effect on the level of 
the  response:  24-30  h  for  the  human cells  and 
18-20 h for mouse cells. 
In  order  to  define  further  the  period  during 
which the cells are sensitive to colchicine, experi- 
ments  were  performed  in  which  the  drug  was 
introduced into cultures of human lymphocytes at 
various times  after  the  addition of Con  A  in a 
fashion analogous to the addition of aMM (Fig. 6 
b).  If colchicine  was  added  at  the  start  of the 
culture,  the  incorporation  of  pH]thymidine  as 
measured at 48 h was inhibited by about 90% when 
compared to controls. Successively less inhibition 
was observed the later the addition of colchicine, 
and no effect  was seen if the drug was added 30 h 
after the  addition of the mitogen. Moreover, the 
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FIGURE 6  Effect  of aMM (a) and colchicine  (b), added at different times after the start of the culture, on 
the incorporation of ['H]thymidine in human lymphoctyes stimulated by Con A. Cultures containing Con 
A (20 ,g/ml) were made 0.1 M in aMM (a) or 10-' M in colchicinr (b) at the indicated time points. The 
cultures were continued until 48 h at which time they pulsed with 6/zCi  of [SH]thymidine  for 2 h and 
harvested.  For  scintillation counting, 50%  and  100% of each of the  aMM  and  colchicine cultures, 
respectively, were used. In both  (a)  and  (b), the  points  labeled CA  represent the  incorporation  of 
[SH]thymidine  by cultures containing only cells plus Con A. The points labeled CC represent incorporation 
by cultures containing cells alone. 
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leled  the  effect  of saccharide  addition  at  various 
times  after  stimulation  (Fig.  6).  These  results 
suggest the possibility that  the inhibitory effect of 
colchicine on lymphocytes takes place at or before 
cellular commitment to lectin activation. 
Specificity  and Reversibility  of the 
Effects of Colchicine 
The  specificity  of  the  effects  of colchicine  on 
lymphocyte stimulation was studied using vinblas- 
tine, vincristine, and lumicolchicine. At concentra- 
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FIGURE  7  A comparison of the effects of colchicine and lumicolchicine on the kinetics of appearance of 
blast cells and on the kinetics of [SH]thymidine incorporation in human lymphocytes  stimulated by Con A. 
Colchicine and lumicolchicine were present from the beginning of the experiment. At the indicated  times, 
aliquots of cultures were removed and the total number of viable lymphocytes and blast cells were counted 
in a hemocytometer. The data are averages of determinations on duplicate cultures and are expressed  as the 
percentage of blast cells present at various times after the addition of Con A (a).  For measurements of 
DNA synthesis (b), data points were obtained from the same experiment as in Fig. 3. O, cultures containing 
Con A (20/zg/ml); m  cultures containing Con A (20 vg/ml) +  colchicine (10-e M); A, cultures containing 
Con A (20 ~tg/ml) +  lumicolchicine (10  -6 M); O, cell control (CC). 
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vinblastine and vincristine, also inhibited the stim- 
ulation  of  human  lymphocytes  by  Con  A  as 
assayed  by  [SH]thymidine incorporation.  In  con- 
trast,  lumicolchicine, a  photo-inactivated deriva- 
tive of colchicine (39), had no appreciable effect on 
the level of blast transformation or DNA synthesis 
in lymphocyte cultures stimulated by Con A (Fig. 
7).  Moreover,  the  extent  of  inhibition  of 
[SH]thymidine incorporation by l0 -8 M colchicine 
was  similar  in  the  presence  and  absence  of  an 
equimolar  concentration  of  iumicolchicine.  This 
suggests that lumicolchicine does not compete with 
colchicine in binding to the inhibitory site involved 
in control of lymphocyte stimulation. 
To  test  whether  the  uptake  of colchicine into 
human lymphocytes can be reversed by washing in 
culture medium free of colchicine, the binding and 
the efficiency and rate of removal of [aH]colchicine 
were determined (Fig.  8).  Colchicine binding was 
rapid during the first 6 h of exposure to the drug at 
a concentration of 10 -6 M; approximately 80% of 
the  maximal colchicinr  level was  reached  within 
this time. A  slower rate of uptake was seen over 
the next 6-10 h. The rate of colchicine efflux was 
slower than  the rate of uptake.  6 h after washing, 
more  than  70%  of the  initially bound  colchicine 
remained associated with the cells. After an expo- 
sure of 6 h to colchicine, not all of the drug can be 
removed by washing and incubating in colchicine- 
free medium. The amount of colchicine remaining 
in  the  cell  even  after  extensive  incubation  was 
about 30% of the maximal level. 
Using these data  on [SH]colchicine uptake and 
efflux  in  human  lymphocytes,  experiments  were 
performed to investigate whether cells treated with 
colchicine become irreversibly refractory to Con A 
stimulation. Cells were exposed to  10 -8 M  or 10 -v 
M  colchicine in  the  absence  of Con  A  for  6  h, 
washed,  and  then  reincubated  in  colchicine-free 
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FIGURE 8  The rates of binding and removal of colchicine on human lymphocytes in the presence of con A. 
Cells (1  ￿  10'/ml) were cultured  in the presence of Con  A (20 ~g/ml) and  10-" M  [IH]colchicine (3 
Ci/mmol). At the times indicated by the arrows, parallel sets of cultures were washed and reincubated in an 
equal  volume  of  colchicine-free  medium  containing  Con  A.  The  solid  line  depicts  the  results  of 
measurements made immediately after the washing was performed. The dotted lines depict the results of 
measurements made on cultures incubated for 6, 12, or 24 h after washing, and also 48 h after the addition 
of [aH]colchicine. The experimental procedure used in these measurements is described in Materials  and 
Methods.  Data points shown are the average of measurements on duplicate cultures and are expressed as 
cpm per  10  e viable cells determined  at the indicated times. Assuming a counting efficiency of 20% for 
SH-scintillation counting, the maximal level of [~H]colchicine (5.5 x  l0  s cpm/10  e cells) corresponds to a 
value of 2.5  x  10  e colchicine molecules per cell. 
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The Reversibility of the Effect of Colchicine* 
Preincubation  Con A  cpm 
Control  -  4,300 
"  +  28,900 
Colchieine (10-' M)  -  4,600 
"  +  26,900 
Colchicine (10  -e M)  -  5,500 
"  +  15,900 
* Human  lymphocytes  were incubated  with or without 
colchicine  for  6  h,  then  incubated  in  coichicine-free 
medium  for 48 h. The cells were then  stimulated  with 
Con A and assayed for [SH] thymidine incorporation  (6 
~Ci/tube, 2 h) 48 h after the addition of the lectin. The 
cpm  shown are  averages  of  results  from  duplicate 
cultures. 
medium  for  another  48  h.  At  this  time,  cell 
viabilities were determined for cultures previously 
exposed and unexposed to colchicine and the cell 
concentrations were brought to 106 viable ceUs/ml. 
The  cells were  then  stimulated with  Con  A  and 
[SH]thymidine incorporation was assayed in these 
cultures 48 h after the addition of the mitogen. The 
results (Table II) show that, while cells exposed to 
10-'  M  colchicine were  fully responsive to  Con 
A-stimulated DNA synthesis as compared to con- 
trols, cells exposed to 10 -e M colchicine recovered 
only partially. The  response  of cells exposed to 
10 -6 M  colchicine was approximately 55%  of the 
level  seen  in  cells  never  exposed  to  the  drug. 
Histologic staining  and  autoradiographic experi- 
ments showed that this corresponds to the percent- 
age of cells responding to  stimulation when  cul- 
tures with and without the drug are compared after 
colchicine removal.  These  data indicate that  the 
effect of colchicine on lymphocyte activation must 
be at least partially reversible, particularly in view 
of the fact that  10 -~ M  colchicine was found to be 
a  potent  inhibitor  of  Con  A-stimulated  DNA 
synthesis (Fig. 2). 
DISCUSSION 
This study was undertaken to investigate in detail 
the  effect  of  colcbicine  on  the  stimulation  of 
iymphocytes by mitogens, particularly in the light 
of the hypothesis that colchicine-binding proteins 
play  a  role  in  mediating  receptor-cytoplasmic 
interactions  (8,  41,  42).  We  previously reported 
that the stimulation of mouse lymphocytes by Con 
A, as measured by [aH]thymidine incorporation in 
the  period  from  48  to  50  h,  was  inhibited  by 
colchicine at a concentration as low as 10 -6 M (8). 
We have now observed similar effects of this drug 
using  human  and  rabbit  peripheral lymphocytes 
stimulated by Con A. The effect of these drugs has 
also been reported recently by Medrano et al. (26) 
using human lymphocytes stimulated by PHA. 
A  satisfactory  interpretation  of the  effects  of 
colchicine on  the  stimulation  of human  lympho- 
cytes by Con A rests on the following observations 
made in the present study: (a) colchicine inhibits 
the mitogenic response at a very early point, before 
the onset of blast transformation and  DNA syn- 
thesis; (b) under the conditions used, exposure of 
unstimulated lymphocytes or blast cells to colchi- 
cine for as long as 30-36 h does not result in any 
appreciable decrease in cell viabilities; (c) colchi- 
cine  does  not  affect  DNA  synthesis in  synchro- 
nized,  prestimulated blast cells; (d) the effect  of 
colchicine on Con A-stimulated blast transforma- 
tion and  [SH]thymidine incorporation can also be 
observed using vinblastine and vincristine but not 
lumicolchicine; and (e) the inhibition by colchicine 
is at  least partially reversible. We shall consider 
each of these in turn. 
The  inhibition  by  colchicine  of  lymphocyte 
activation cannot  be  solely ascribed to the  well- 
known  effect  of the  drug  on  the  mitotic spindle 
(31).  It has been reported previously (32) that the 
majority of the  mitogen-stimulated human  lym- 
phocytes enter their first mitosis between 48 and 60 
h after the initial binding of the stimulant. We have 
found, however, that a difference in both the levels 
of  DNA  synthesis and  blast  transformation  be- 
tween Con A-stimulated lymphocyte cultures with 
and without colchicine can be observed as early as 
36  h  (Figs.  3  and  4).  Therefore,  the  onset  of 
division in Con  A-stimulated cultures occurs too 
late to support the contention that colchicine acts 
by metaphase arrest. 
It  is  also  clear  that  the  inhibitory  effects  of 
colchicine and related drugs cannot be ascribed to 
their toxicity. Although it has been reported that 
antimitotic agents  such  as colcemid, vinblastine, 
and vincristine are highly toxic to certain mamma- 
lian  cell  lines  at  concentrations  comparable  to 
those  used  in  the  present  experiments  (18,  23), 
Thompson  and  O'Connor  (37)  have  found  that 
normal human lymphocytes are resistant to rapid 
killing by colchicine. In addition, Medrano et ai. 
(26)  have  reported that  colchicine, at  concentra- 
tions as high as 2.5  ￿  10 -~ M, does not affect the 
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as  72  h  in  culture.  Our  results  also  show  no 
significant difference in the number of either blast 
cells or nonresponding lymphocytes between syn- 
chronized cultures with and without  10 -8 M  col- 
chicine for exposure times of up to 30 h  (Fig. 5). 
When  asynchronous  cultures  stimulated  with 
Con A were maintained in the continuous presence 
of colchicine (Table  I), an  apparent reduction in 
the total cell number is seen at 46, 55, and 67 h, as 
compared to the corresponding number in cultures 
containing  only  Con  A.  Interpretation  of  this 
observation is complicated, however,  by the fact 
that  cell division commences at  about 45  h  after 
the  addition  of the  mitogen  (32),  resulting  in  a 
relative increase in the number of cells in cultures 
containing Con A  alone. Inasmuch as a difference 
in  both  DNA synthesis and  blast transformation 
can be detected before the reduction in cell number 
due  to  colchicine becomes  appreciable, we  con- 
clude that the effect of colchicine on mitogenesis 
cannot be due to cell death induced by the drug. 
Two  other lines of evidence argue  against cell 
death  as  the  cause  of  inhibition  of  mitogenic 
stimulation  by  colchicine.  First,  the  observation 
that  the  colchicine  effect  is  at  least  partially 
reversible suggests  that  the  cells are  not perma- 
nently damaged.  Second, both  [SH]thymidine in- 
corporation  and  blast transformation  in  cultures 
containing colchicine increase after 50 h, implying 
that  the  cells are still viable and  can  escape the 
colchicine block at late times. 
This  late  rise  of  DNA  synthesis  and  blast 
transformation  in  cultures  containing  colchicine 
may indicate that the effect of colchicine is to slow 
the passage of a cell through a given phase of the 
cell  cycle.  It  has  been  reported  that  at  high 
concentrations,  such  as  10-'  M,  colchicine  can 
inhibit DNA synthesis (10, 19) or slow the passage 
of a cell through the S phase (15, 16). Other studies 
have  shown  that  lower concentrations  of colchi- 
cine (1-5  ￿  10 -s M) can inhibit thymidine trans- 
port  in  a  variety of cell lines (27)  and  in  rabbit 
alveolar macrophages (5).  In our studies, we have 
found  that  10 -6  M  colchicine  does  not  inhibit 
either  DNA  synthesis or thymidine transport  in 
blast cells stimulated in the absence of colchicine 
and  collected  at  the  G1/S  boundary  using  hy- 
droxyurea. A similar conclusion has been made by 
Medrano et al. (26) for human lymphocytes stimu- 
lated with PHA, except that these workers added 
colchicine only  3  h  prior to the  measurement  of 
DNA  synthesis.  From  our  binding studies using 
[SH]colchicine (Fig. 8), we estimate that the intra- 
cellular level of colchicine as a  result of the 3-h 
preincubation with the drug would be about 50% 
of the maximal level. Both studies, therefore, indi- 
cate that in colchicine-containing cultures, the in- 
hibition of [SH]thymidine incorporation is not due 
to an inhibition by the drug of thymidine transport 
or the process of DNA synthesis itself. 
One can  now  ask the following questions con- 
cerning the effect of colchicine: (a) At what stages 
of the cell cycle does colchicine exert its inhibitory 
effect  on  the  cell?  (b)  Are  all  responding  cells 
susceptible to  inhibition  simultaneously? To  an- 
swer these questions,  it is first necessary to con- 
sider the heterogeneity of the response of the cell 
population to Con A. 
The  kinetics  of  cellular  commitment  in  the 
stimulation of mouse splenocytes by Con A  have 
recently been analyzed (13). As used here, "com- 
mitment"  is  the  point  at  which  a  cell becomes 
stimulated and no longer depends upon the pres- 
ence  of the  mitogenic agent.  It  has  been  shown 
that,  for  mouse  lymphocytes,  all  cells  do  not 
become committed to stimulation simultaneously, 
but  rather  at  various times  up  to  20  h  after the 
addition  of  the  mitogen.  Other  workers  using 
human lymphocytes have also observed an increas- 
ing  response  with  longer  incubations with  PHA 
(43) or Con A (21, 29), although the specific result 
differs according to the conditions of the assay and 
the method of removal of the lectin. It is important 
to  emphasize  that  these  conclusions  concerning 
cellular commitment apply only to those cells that 
have entered their initial S phase by 48 h. There is 
ample evidence  from  studies of PHA-stimulated 
human lymphocytes that the period between iectin 
addition  and  the  entry  of a  cell into  the  first S 
phase  is  highly variable (17,  34,  35).  Moreover, 
data on the commitment time for cells entering S 
phase  after 48  h  are  not  easily analyzed due to 
complications introduced by daughter cell prolifer- 
ation. In any event, the data presented here (Fig. 6 
a)  suggest  that  increasing  numbers  of  human 
lymphocytes  become  committed,  beginning  with 
the time of addition of Con A and continuing up to 
30 h after the addition of the lectin. 
Given  the  facts  on  the  kinetics  of  cellular 
commitment,  what  is  the  temporal  relation  be- 
tween inhibition by colchicine and commitment to 
stimulation? The two  alternatives are: (a) coichi- 
cine inhibits mitogenic stimulation near the time 
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either before or after commitment. These alterna- 
tives lead to different predictions about the effects 
of  colchicine  added  at  various  times  to  Con 
A-stimulated  cultures  (Fig.  6  b).  If  the  first 
alternative is true, then the addition of colchicine 
at later and later times will result in an increasing 
response  similar to that  observed when  aMM  is 
added  at  various  times  (Fig.  6  a).  If colchicine 
inhibits before or after commitment, however, then 
the colchicine-sensitive point and the commitment 
point can  be separated by either a  constant time 
interval  from  cell to  cell,  or  by  a  variable time 
interval. Separation of the two points by a constant 
time,  t,  would  generate  a  curve  (Fig.  6  b)  that 
paralleled  the  curve  for  aMM  addition,  with  a 
shift of the colchicine curve to earlier or later times 
by an interval equal to time t. If, on the other hand, 
the  colchicine-sensitive  point  and  the  commit- 
ment  point  are  separated  by  a  variable  time 
interval, the possibilites become too numerous for 
analysis to be useful. The fact that the two curves 
in Fig. 6 a and b are similar is at present consistent 
with the interpretation that the inhibitory action of 
colchicine takes  place  near  the  time  that  a  cell 
becomes committed to stimulation by Con A. 
The cellular sites of the inhibition by colchicine 
are not  known.  We have  reported previously (8) 
that colchicine does not interact with Con  A  nor 
does it inhibit the ceil-binding activity of the pro- 
tein.  Our  present  studies  using  colchicine,  vin- 
blastine,  vincristine,  and  lumicoichicine  suggest 
that  the  inhibition  may  be due to  interaction of 
the drugs with microtubules rather than  to inter- 
action with some component within the cell mem- 
brane.  While colchicine, vinblastine, and  vincris- 
tine  inhibited  mitogenic  stimulation,  lumicolchi- 
cine did not.  In processes usually associated with 
the interaction of colchicine with membrane com- 
ponents, such as inhibition of nucleoside transport, 
lumicolchicine is just  as effective an  inhibitor as 
colchicine while vinblastine does not inhibit (5, 27, 
38).  Moreover, we have found that colchicine in- 
hibited  the  stimulation  of  lymphocytes  to  the 
same extent in the presence and absence of equi- 
molar  concentrations  of  lumicolchicine.  Inas- 
much  as  lumicolchicine does  not  compete  with 
colchicine for  binding  sites on  microtubules (38, 
39),  these results are consistent with the interpre- 
tation that the site of action of colchicine on the 
early events in  mitogenesis may  be microtubular 
structures within the cytoplasm. 
The  observation that  the  binding of [SH]colchi- 
cine  to  human  lymphocytes  and  the  effect  of 
colchicine on cell stimulation are partially reversi- 
ble is consistent with evidence from the binding of 
the drug to tubulin subunits in vitro and from ex- 
periments on  modulation of receptor mobility. If 
purified  tubulin  is  saturated  with  colchicine and 
then  incubated for 6  h  in the absence of any free 
colchicine, only 12% of the colchicine-binding sites 
are unoccupied (38). This is to be compared with a 
half-life of about  12  h  for the  loss of colchicine 
from  human  lymphocytes  (Fig.  8).  Yahara  and 
Edelman (41) also found that the effect of colchi- 
cine on the modulation by Con  A  of lymphocyte 
surface receptor mobility is only partially reversed 
after 6 h of incubation in colchicine-free medium. 
It is interesting to note that Taylor (36), using 10 -* 
M  colchicine, found that the intracellular level of 
the drug in a human cell line was reduced by 75% 
after  only  7  h  of  incubation  in  colchicine-free 
medium. This suggests that at  l0 -7 M  the degree 
of reversibility in the binding of colchicine is much 
higher  than  at  10 -6  M.  In  agreement  with  this 
conclusion, treatment of lymphocytes with 10- ~ M 
colchicine resulted in a higher degree of reversibil- 
ity  than  was  observed  at  higher  concentrations 
(Table II). 
All of the present findings, as well as those on 
the  effects  of  colchicine  on  the  modulation  of 
receptor mobility (41, 42), have important implica- 
tions  for  hypotheses on  receptor-cytoplasmic in- 
teractions  and  mitogenesis  in  lymphocytes  (8). 
Inhibition  by  Con  A  of  cell  surface  receptor 
movement  and  its reversal by colchicine suggests 
that  a  colchicine-binding protein system  such  as 
the  cytoplasmic  microtubules  may  mediate  the 
inhibition  process  (8,  41,  42).  The  inhibition  by 
colchicine of the  stimulation  of lymphocytes by 
Con  A  suggests  the  possibility  that  mitogenic 
activation  could  also  be  mediated  by  the  same 
structures which are responsible for the appropri- 
ate receptor-cytoplasmic interactions. 
Alternatively, the  effect  of colchicine on  lym- 
phocyte  stimulation  could  be due  to  the  control 
exerted by microtubular proteins on the transport 
of  various  ions  and  metabolites.  For  example, 
recent studies have shown that Ca ++ ion uptake is 
required for lymphocyte activation (l, 3) and that 
the Ca++-carrying ionophore A-23187 can stimu- 
late human  lymphocytes (J.  L.  Wang and G.  M. 
Edelman, unpublished observations) and pig lym- 
phocytes (24). Furthermore, one of the early events 
142  THE  JOURNAL OF  CELL  BIOLOGY. VOLUME 66,  1975 after mitogen binding is the increased metabolism 
of phospholipids,  particularly phosphotidylinositol 
(9),  which  may  be  controlled  by  changes  in  the 
intracellular concentration  of free Ca ++  (2). 
In view of these observations, it is interesting to 
consider the possibility that  an intact microtubule 
assembly  may  be  necessary  for  Ca ++  ion trans- 
port. Colchicine may exert its inhibitory effects by 
dissociating  the  microtubules,  which  regulate  the 
required Ca ++ ion transport in a fashion analogous 
to the regulation of other Ca + +-sensitive processes 
such as insulin release by pancreatic islet cells (20) 
and granulocyte chemotaxis (11).  The demonstra- 
tion  of such  a  formal analogy between the stimu- 
lus-secretion coupling system and lymphocyte mi- 
togenesis (30) promises to deepen our understand- 
ing of the mechanism of lymphoid cell stimulation. 
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